Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - marbofloxacin - oral tablet - marbofloxacin antibiotic active 100.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - bacillus spp. | beta-hemolytic streptococcus (not a or b | corynebacterium spp. | enterococcus faecalis | escherichia coli (e. coli) | infections of the skin | infections of the urinary tracts | klebsiella pneumoniae | pasteurella multocida | proteus mirabilis | pseudomonas aeruginosa | pseudomonas spp. | soft tissue infections | staphylococcus aureus | staphylococcus intermedius | streptococcus spp. | abscesses | anal sacculitis | bacterial canker | deep pyodermas | escherichia coli | fowl cholera | fungal | gingivitis | gram negative bacteria | gram positive bacteria | group d streptococcus | including b-lactamase producin | including secondary invaders | klebsiella spp. | not group a | not group b | post-parturient infections | proteus spp. | pseudomonas aeruginosa | pyoderma | seborrhoeic dermatitis | septicaemia | staphylococcus spp. | yeast

United States - English - NLM (National Library of Medicine)

zyvet animal health inc - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United States - English - NLM (National Library of Medicine)

felix pharmaceuticals private limited - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United States - English - NLM (National Library of Medicine)

zoetis inc. - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin 25 mg - zeniquin (marbofloxacin) tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

United States - English - NLM (National Library of Medicine)

professional compounding centers of america - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin ep (for veterinary use) for veterinary use only. part: 30-5151 gm cas: 115550-35-1 avoid contact with eyes and skin. avoid breathing dust, vapor, mist or gas. store in tightly closed container. store at room temperature.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - marbofloxacin - unknown - marbofloxacin antibiotic active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - marbofloxacin; clotrimazole; dexamethasone acetate - misc. aural, ophthalmic, oro/naso pharyngeal - marbofloxacin antibiotic active 3.0 mg/ml; clotrimazole imidazole active 10.0 mg/ml; dexamethasone acetate steroid-glucocorticoid active 1.0 mg/ml - ear,nose,throat preps. - dog | bitch | castrate | puppy - otitis externa | acute canine otitis | associated with yeast &/or bac | chronic canine otitis | malassezia pachydermatis | otitis (canine)

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin 247.5 g in 250 g

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin 49.5 g in 50 g